Modular Medical Board Sees Surge of Insider Purchases: Multiple Directors Exercise 250‑Share Options at $4.55 Amid 15% Monthly Decline.

Insider Activity Spotlight: Frank Morgan C. and the March 31, 2026 Options Exercise

On March 31, 2026, Frank Morgan C., a member of Modular Medical’s board and outside director, exercised a pair of fully‑vested options under the company’s Outside Director Compensation Plan. The two transactions—each covering 250 shares—were recorded as “buy” trades, bringing Morgan’s total holdings to 312 shares. The options were exercised at a price of approximately $4.55 per share, well below the current market price of $5.10, indicating a favorable cost basis for the director.

Implications for Investors

While the absolute number of shares involved is modest, the timing of Morgan’s exercise aligns with a broader wave of insider activity that day. Several other directors—including Vos Ellen O’Connor, Jeff Goldberg, Philip Brent, Steven Felschwer, and Duane DeSisto—also exercised 250‑share options on March 31. This cluster of transactions suggests a coordinated utilization of the vesting schedule rather than a reaction to any single market event. For investors, the key takeaway is that the board remains committed to the long‑term upside of Modular Medical; their cost‑effective purchases reinforce confidence in the company’s trajectory despite recent volatility.

What It Means for the Company’s Future

Modular Medical’s stock has struggled sharply in 2026, sliding 15.66 % in the month and 81.17 % year‑to‑date. The recent 1‑for‑30 reverse split has compressed share counts, yet the company’s market cap remains under $24 million. The director exercises at a price well below the trading level imply that insiders are not alarmed by the decline and are prepared to absorb additional shares at a discount. This could be a signal that the board believes the technology—particularly the injection‑free delivery system—is still poised for a resurgence. However, the sheer volume of insider buys is dwarfed by the broader market sentiment, which has shown a neutral social media tone (sentiment = 0) but moderate buzz (12.35 %), indicating that the market is not yet fully aligned with insider optimism.

Frank Morgan C.: A Pattern of Strategic Purchases

Frank Morgan’s transaction history shows a consistent pattern of exercising options in sizeable batches. In both March and September of 2025, he purchased 7,500 and 1,875 options respectively, totaling 9,375 shares each time. These purchases were always executed at the same exercise price of $4.55, the same level as the March 2026 exercise. Morgan’s holdings have grown steadily, reflecting a long‑term commitment. The timing—often shortly after grant dates—suggests a disciplined approach: he exercises as soon as options vest, maintaining a low cost basis and aligning his interests with those of the shareholders.

Takeaway for Financial Professionals

For analysts and portfolio managers, Morgan’s recent activity should be viewed as a positive, albeit incremental, sign of insider confidence. The synchronized exercises across the board hint at a unified endorsement of Modular Medical’s strategy. While the company’s share price remains weak, the directors’ willingness to purchase at a discount underscores their conviction that the underlying technology—and the broader health‑care market—will ultimately drive value. Investors should weigh this insider sentiment against the broader market dynamics and consider a watchful, long‑term perspective rather than reacting to short‑term price swings.